Selective priming of rate and duration of the respiratory burst of neutrophils by 1, 2-diacyl and 1-O-alkyl-2-acyl diglycerides. Possible relation to effects on protein kinase C. by BASS, D. et al.
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1989 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 264, No. 36, Issue of December 25, pp. 19610-19617,1989 
Printed in U.S.A. 
Selective Priming of Rate  and  Duration of the  Respiratory  Burst of 
Neutrophils  by 1,a-Diacyl and l-O-Alkyl-2-acyl Diglycerides 
POSSIBLE RELATION TO EFFECTS ON PROTEIN KINASE C* 
(Received for publication, November 18, 1987) 
David A.  BassSQT, Linda C.  McPhailQ, Jeffrey D. SchmittQ, Susan  Morris-Natschke, 
Charles E. McCallS, and  Robert L. WykleQ 
From the Departments of $Medicine and §Biochemistry,  Bowman  Gray School of Medicine of Wake Forest University, Winston- 
Salem, North Carolina 27103 and the 11 Department of Medicinal Chemistry,  University of North Carolina, Chapel  Hill, 
North Carolina 27103 
Both 1,a-diacyl- and l-O-alkyl-2-acyl-sn-glycerols 
are released  during  stimulation of human  polymorpho- 
nuclear  leukocytes  (PMNL).  1,2-Diacylglycerols  have 
received  intense  interest as intracellular “second mes- 
sengers’’ due  to  their  ability  to  activate  protein  kinase 
C (Ca2+ phospholipid-dependent enzyme). However, 
little is known about bioactivities of the alkylacyl- 
glycerols. This  study  compared  the  ability of 1,a-dia- 
cyl- and l-O-alkyl-2-acylglycerols to  modulate  the r s- 
piratory  burst of stimulated PMNL, a response  which 
depends on the activation of an NADPH oxidase to 
generate  bactericidal species of reduced  oxygen. Direct 
stimulation  by  N-formyl-Met-Leu-Phe  caused an ab- 
rupt release of Hz02 which ceased within 2.5 min. 
Preincubation  with  diacylglycerols  (l-oleoyl-2-acetyl- 
glycerol, 5-30 pM, and 1,2-dioctanoylglycerol, 2-5 pM) 
caused a decrease  in  lag  time,  %fold  increase  in  initial 
rate of Hz02 release, and  marked  prolongation of the 
response  to  N-formyl-Met-Leu-Phe  (features  charac- 
teristic of a priming effect). Preincubation with al- 
kylacylglycerols (l-O-A9-octadecenyl-2-acetylglyc- 
erol, 5-30 p ~ ,  and l-O-octyl-2-octanoylglycerol, 20- 
50 p ~ )  primed  initiation  (shortened  lag  time  and  in- 
creased velocity) but, in contrast to diacylglycerols, 
did  not alter  duration of HzOz release. 
While low concentrations of diacylglycerols (5-30 
p ~ )  primed PMNL, higher concentrations (270 p ~ )  
stimulated the cells  directly.  In  contrast,  higher (70- 
100 p ~ )  concentrations of alkylacylglycerols  did  not 
prime the responses but, in fact, inhibited priming 
(especially of duration) induced  by  diacylglycerol. The 
high  concentrations of alkylacylglycerol  also  inhibited 
direct  stimulation  induced  by  high  concentrations of 
diacylglycerol.  Direct  stimulation  by  high  concentra- 
tions of diacylglycerol  probably  involves activation of 
protein  kinase C, whereas  alkylacylglycerol  was  found 
to  inhibit  activation of protein  kinase C by diacylglyc- 
erol in vitro. Thus,  diacylglycerols are complete prim- 
ing agonists, altering both rate and duration of the 
response. In  contrast,  alkylacylglycerols  may  have  bi- 
phasic, concentration-related  effects  in modulation of 
functions of PMNL. At low  concentrations,  they  may 
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facilitate  initiation of functional  events;  however, as 
their  concentration  increases,  they  may  serve  to  ter- 
minate responses. 
The  distinct  priming  effects of these  diglycerides  also 
r veal  that  priming  can  involve at least  two  distinct 
events: 1) initiation  and 2) prolongation.  The  separate 
modulation of these  events  indicates  that  initial  acti- 
vation of the NADPH oxidase and  maintenance of sub- 
sequent  oxidase  activity  require  different  intracellular 
mechanisms. 
Normal bactericidal function of human polymorphonuclear 
leukocytes (PMNL)’ depends upon stimulation of a  respira- 
tory burst (1, 2). This involves activation of the NADPH 
oxidase, a multicomponent electron transport chain which 
transfers electrons from intracellular NADPH to extracellular 
(or phagosomal) oxygen, with the  net production of superox- 
ide and HzOz. Enhanced oxidative responses may  be observed 
if normal PMNL  are preincubated with one agonist and  then 
stimulated with a different agonist (3-14). This increased 
responsiveness has been referred to as “priming” (5, 15), and 
as employed previously (14), the following terminology will 
be used in  this report: 
Rest -direct stimulation 
stimulant 
1st agonist 2nd agonist 
(priming agenti (stimulant) 
Rest 
The primed response is greater than would  be predicted by 
an additive effect of the two agonists alone, and maximal 
priming involves all the following kinetic aspects of the res- 
piratory burst: shortened lag time, increased velocity, and 
prolongation. Priming is not a mere in vitro phenomenon; 
priming -primed stimulation 
cytes; fMLP, N-formyl-methionyl-leucyl-phenylalanine; EGTA, [eth- 
* The abbreviations used are: PMNL, polymorphonuclear leuko- 
ylenebis(oxyethylenenitrilo)]tetraacetic acid; alkyl-PC, l-O-alkyl-2- 
acyl-sn-glycero-3-phosphocholine; HBSSg, Hanks’ balanced salt so- 
lution with addition of 5 mM glucose and 0.1% gelatin; PAF, platelet 
activating factor (l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocho- 
line);  PC, choline-containing phosphoglycerides; PKC, calcium and 
phospholipid-dependent protein kinase (protein kinase C); PMA, 
phorbol-12-myristate-13-acetate; TLC, thin layer chromatography; 
V,.it, initial (maximal) velocity; V3 velocity 3 min after stimulation. 
Diglycerides are abbreviated according to side chains linked to  the 
glycerol linkage, with “A” for acyl and “ E  for ether  (alkyl);  chains 
at sn-1 and sn-2 positions are given in parentheses (number of 
carbons:number of double bonds). Thus, AAG, 1,2-diacylglycerol; 
EAG, l-O-alkyl-2-acylglycerol; EEG, 1,2-dialkylglycerol. 
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similar, greater-than-normal respiratory burst responses have 
been reported with granulocytes from patients having ill- 
nesses characterized by myeloid stimulation (16-19). Al- 
though both i n  vivo and i n  vitro priming were observed more 
than a decade ago (3,16),  the mechanism(s) of priming remain 
largely unknown. 
Optimal priming is observed with agonists which activate 
different intracellular stimulus-response coupling mecha- 
nisms (6). Diacylglycerols (AAGs)' have been proposed as 
intracellular second messengers which activate  protein kinase 
C (PKC) in human PMNL (14, 20, 21), as well as  other cells 
(22-24). AAGs are released by a phospholipase C which 
cleaves phosphatidylinositol-4,5-bisphosphate; this pathway 
is activated by binding of certain membrane receptors (e.g. 
receptors for chemotactic peptides) but  is inhibited by phorbol 
myristate acetate (25, 26). Recently, Daniel et al. (27) de- 
scribed a distinct pathway, activated by phorbol myristate 
acetate, which cleaves 1-0-alkyl-2-acyl-sn-glycero-phospho- 
choline (alkyl-PC) to release 1-0-alkyl-2-acyl-sn-glycerols 
(ether acyl  glycerides, EAGs) in the Madin Darby kidney cell 
line; this pathway appeared to be catalyzed by a phospholipase 
C specific for PC.  1-0-alkyl-linked species constitute 46  mol 
% of the  PC fraction of human PMNL (28) which provides a 
source of EAGs. Stimulation with the chemotactic peptide N -  
formyl-methionyl-leucyl-phenylalanine (fMLP), phorbol my- 
ristate  acetate, AAG, or Ca2+ ionophores have been shown to 
cause EAG release in human PMNL (29-31). Thus,  both 1,2- 
diacyl- and 1-0-alkyl-2-acyl-glycerols are released during re- 
sponses of PMNL. 
Biological activities of  AAGs have been generally assumed 
to be due to activation of PKC (7, 8, 20, 22-24, 32). The 
respiratory burst of PMNL is directly stimulated by a cell 
permeant AAGs, 1-oleoyl-2-acetylglycerol (AAG(18:l-2:O)) 
(7, 8, 14, 20) and 1,2-dioctanoylglycerol (AAG(8:O-8:O)) (32). 
Direct stimulation by  AAG(  18:l-2:O) occurs at concentrations 
which cause translocation of PKC from the cytosol to  the 
plasma membrane (14). Lower concentrations of AAG(181- 
2:O) also prime PMNL to produce more reduced oxygen spe- 
cies (e.g. HzO2) in response to fMLP  (7, 8, 14), although such 
priming may  involve mechanisms distinct from classical 
translocation or activation of PKC (14). The biological activ- 
ities of EAGs are largely unknown. EAGs have little or no 
ability to activate PKC in vitro (33, 34) and may actually 
inhibit  PKC activity ((35)  and  this  study)  but could modulate 
cellular function by other mechanisms. EAGs cause differen- 
tiation of the human myeloid leukemia cell line, HL-60, by 
unknown mechanisms (36). Effects of EAGs on functional 
responses by PMNL have not been reported. 
We are investigating the ability of AAGs and EAGs to 
modulate cellular function using synthetic analogs of the 
natural diglyceride  species.  AAG(18:l-2:O) has been used pre- 
viously since it is cell permeant  (20,32). We have synthesized 
the EAG species, l-O-A9-octadecenyl-2-acetylglycerol (EAG 
(181-2:O)) and several similar EAG analogs for comparison. 
The AAG, 1,2-dioctanoylglycerol and its EAG analog, 1-0- 
octyl-2-octanoylglycerol, have also been synthesized and  their 
priming and  stimulatory effects examined. Since activation of 
PKC might have a  central role in  stimulation of PMNL,  the 
effects of AAG(18:l-2:O) and EAG(18:l-2:O) on activity of 
PKC(s) from human PMNL were also studied. 
EXPERIMENTAL  PROCEDURES 
Reagents-PMA, cytochalasin B, and azide were obtained from 
Sigma. fMLP was from Penninsula Laboratories, Belmont, CA. 1 3  
Dioctanoylglycerol (AAG(80-8:O))  was obtained from Molecular 
Probes (Eugene, OR). Octyl bromide, rac-isopropylidene glycerol 
(Soketal), (4,4'-dimethoxy) trityl chloride, and trimethylborate were 
from Aldrich. Octanoyl chloride was from NuChek Prep (Elysian, 
MN). [-p3'P]ATP was from DuPont-New England Nuclear. Hanks' 
balanced salt solution (HBSS) was  from  GIBCO, and Isolymph from 
Gallard Schlessinger (Carle Place, NY). Gelatin was purchased from 
Difco Laboratories (Detroit, MI). 
Synthesis of Diglycerides and Platelet Activating Factor-l-Oleoyl- 
2-acetyl-rac-glycerol (AAG(181-2:0)), l-O-A9-octadecenyl-2-acetyl- 
sn-glycerol (EAG(181-2:0)), 1-0-A9-octadecenyl-2-propionyl-rac- 
glycerol (EAG(181-3:0)), 1-0-hexadecyl-2-hexanoyl-sn-glycerol 
(EAG(16:O-60)), 1-0-hexadecyl-2-acetyl-sn-glycerol (EAG(160- 
2:0)), and 1-0-hexadecyl-2-0-ethyl-sn-glycerol (EEG(16:0-2:0)) were 
synthesized by minor modifications of previously published tech- 
niques (37). Platelet activating factor (1-0-hexadecyl-2-acetyl-sn- 
glycero-3-phosphocholine, PAF) was synthesized according to the 
methods of Surles et al. (38). Ammonia chemical ionization mass 
spectrometry yielded characteristic fragmentation and molecular ions 
for the above compounds. TLC was routinely employed to further 
verify chemical and isomeric purities. The  TLC was carried out on 
Silica gel G layers developed in  ethyl  ether/hexane 6040 (v/v) and 
visualized by HzS04:chromate charring. The 1,2- and 1,3-diglycerides 
are readily resolved in this system. All compounds demonstrated 
>95% chemical and isomeric purity. To minimize acyl migration 
(verified by TLC), the 1,2-diglycerides were stored in hexane at 
1-0-Octyl-2-octanoyl-rac-glycerol (EAG(80-80)) was synthesized 
as follows: rac-isopropylidene glycerol was converted to the octyl 
ether by refluxing with sodium hydride followed by 1-octyl bromide 
in tetrahydrofuran. After cooling, an equal volume of water was 
carefully added. The mixture was extracted with an equal volume of 
ethyl ether  and  the  ether was collected, washed twice with water, and 
then dried over sodium sulfate. After solvent removal, the resulting 
oil was vacuum distilled (100-110 "C at 2 mm Hg) with a yield of 
85%. Acidic hydrolysis of the ketal was carried out by refluxing in 0.5 
N H2S04 for several hours, followed  by stirring at room temperature 
overnight. The solution was extracted twice with equal volumes of 
ethyl ether followed by equal volumes of chloroform. The organic 
phases were combined, dried over sodium sulfate, and freed of solvent. 
The resulting monoglyceride  was vacuum distilled (130-140 "C at 1 
mm Hg), yield 80%. 1-0-octyl-rac-glycerol was protected at  the pri- 
mary hydroxyl position by reacting it with 4,4'-dimethoxytrityl chlo- 
ride using pyridine as  the solvent. The reaction mixture was poured 
into  an equal volume of water and extracted twice with equal volumes 
of ether. After pooling the  ether phases, they were washed with water 
and dried over sodium sulfate. The protected monoglyceride was 
acylated without further purification using octanoyl chloride in  pyr- 
idine. The primary product, 1-O-octyl-2-octanoyl-3-(4,4'-dimethoxy- 
trityl-rac-glycerol was purified after extracting from ethyl ether/ 
water, as above (yield 55%).  The crude material was freed of solvent 
and loaded onto  a silica column (Merck Grade 60 Silica Gel, 230-400 
mesh) and eluted with chloroform. Column fractions were monitored 
by TLC. The most pure fractions were  pooled, the solvent evaporated, 
and applied to another Silica Gel 60 column. The lipid was eluted 
with hexane/ethyl acetate (4:1, v/v). The most pure fractions were 
again collected, evaporated, and loaded onto a third Silica Gel 60 
column employing toluene eluant, giving a >98% pure product. De- 
protection of the primary hydroxyl was carried out by refluxing 100 
mg of lipid and 100 mg of boric acid in 1 ml of trimethyl borate 
overnight. The desired product, 1-0-octyl-2-octanoyl-rac-glycerol 
(EAG(80-8:0)), migrated on TLC with an RF = 0.39 (ethyl ether/ 
hexane, (6040, v/v)). Purification was carried out on preparative 
TLC on borate impregnated plates to minimize acyl migration, using 
the same solvent system. Impregnation was achieved by prerunning 
1-mm  thick Silica Gel G  plates  in  water/ethanol (l:l, v/v) saturated 
with boric acid, then activating overnight at 100 "C. Purity of the 
EAG(8:0-80) was >95% and was routinely examined for acyl migra- 
tion by TLC. With this purification method, no contamination by 
the diacyl analog, AAG(80-80) should occur. This was confirmed by 
mass spectrometry. 
For each experiment, aliquots of diglyceride or PAF solutions were 
dried under NZ and suspended by sonication in HBSS  containing 2.5 
mg/ml  bovine serum albumin (final bovine serum albumin concen- 
trations in the assays was less than 0.25 mg/ml). 
Preparation of PMNL-PMNL were isolated by a modification of 
the technique of Boyum (39) as described previously (40). Granulo- 
cytes were  washed  by centrifugation and resuspended in  HBSS con- 
taining  5 mM glucose and 0.1% gelatin, without added Ca2+ or Mg2+ 
(HBSSg). PMNL concentration was determined by standard hemo- 
cytometer techniques. PMNL were kept at 5 X lO'/ml at 4 "C until  5 
-70 "C. 
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min before study, a t  which time they were warmed to 37 “C  and 1 
mM Ca2+ (final concentration) was added to the buffer. Viability, 
assessed by trypan blue exclusion, was >95% and was not changed 
by preincubation with the diglycerides employed. 
Priming and Stimulation Protocok-If the time of stimulant  ad- 
dition is considered time 0, at t = -151 min, PMNL were diluted to 
5 X 106/ml in prewarmed, air-saturated HBSSg with 1 mM Ca2+. At 
t = -10 min, the priming agent (or buffer) was added as appropriate 
to  the experiment. At t = -2 min, 5 pg/ml cytochalasin B (unless 
stated otherwise) and 2 mM azide  were added, followed  by stimulant 
addition at t = 0. Azide  was included to inhibit catalase and myelo- 
peroxidase which  would cause catabolism of H202  to water (peroxi- 
dase) or to regeneration of 0 2  (catalase) and thereby cause unpre- 
dictable changes in net O2 consumption and  H202 release. 
In  certain experiments, the effect of removal of extracellular di- 
glyceride was examined as follows: PMNL were prewarmed and 
diglyceride added, as above. After 2.5 min, the cells were  washed  by 
brief (5 min) centrifugation and resuspended in the same buffer, but 
lacking diglyceride. They were then treated with cytochalasin B and 
stimulated with fMLP, as in the standard priming protocol. 
Measurement of Hydrogen Peroxide Release and Oxygen Consump- 
tion-Hydrogen peroxide release was measured polarographically us- 
ing an oxidase probe, and oxygen consumption was measured using a 
Clark oxygen electrode (both from Yellow Springs Instruments, Yel- 
low Springs, OH) in a 37 “C water-jacketed, dual electrode, 2-ml 
cuvette (Gilson Medical Electronics, Middleton, WI). Both Hz02 
release and 0 2  consumption were recorded simultaneously using a 
homemade nanoammeter. H202 was calibrated by addition of 10 p~ 
Hz02 to the cuvette. The relative sensitivity of the Hz02 and 0 2  
electrodes was also calibrated by addition of glucose oxidase plus 
glucose to  the cuvette; a stoichiometry of 0 2  consumption to Hz02 
generation of 1:l was assumed. The two methods of  Hz02 calibration 
agreed within 15%. Zero oxygen concentration was calibrated by 
addition of sodium dithionite, and  the 0 2  concentration of the air- 
saturated buffer was assumed to be 200 p ~ .  The measurement of 
Hz02 generation was roughly 10-fold more sensitive than  that of 0 2  
consumption and was considered the more precise measure of the 
responses. Therefore, the Hz02 data  are given in this report. In all 
instances, oxygen consumption paralleled Hz02 release, except that 
slight O2 consumption continued after cessation of detectable release 
of H202.  The “initial velocity” ( Vi.it) is the maximal rate of response. 
Since the response of fMLP normally terminated in less than 2.5 
min, the rate of response occurring 3 min after stimulation (Varnin) 
was used as  an indicator of prolongation of the respiratory burst. 
Protein Kinase C Assays-Previously described techniques (21,41) 
were employed. Briefly, PMNL,  5 X 107/ml, were suspended in 
extraction buffer containing 50 mM Tris-HC1, 2 mM EGTA, 50 mM 
2-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride, pH 7.4. 
The  PMNL were sonicated and fractionated as described (21). After 
a 500 X g centrifugation to remove nuclei and unbroken cells, the 
supernatant was centrifuged at 150,000 X g for  90 min; the resultant 
supernatant, referred to as “cytosol,” was used to assay for PKC 
activity in PMNL (with resting PMNL, under these conditions, 
virtually all PKC activity is in this soluble fraction). The PKC assay 
(21) measured the incorporation of 32P from [y3’P]ATP  into type 
H1 histone and was performed at 30 ‘C in the presence or absence of 
0.6 mM added Ca2+ (0.2 mM free Ca2+), 20 pg/ml phosphatidylserine, 
and  the indicated concentration of diglyceride. PKC activity is ex- 
pressed as pmol of 32P incorporated/min/lO’ cell equivalents. 
Statistical Anulysis-Data are expressed as means & S.E. The 
number of determinations ( N )  refers to the number of separate 
PMNL preparations studied. Nonlinear regression employed a mod- 
ification of the Marquardt algorithm (42) (Graph-Pad, IS1 Software). 
Significance was tested with the Student’s t test (paired or unpaired) 
or Wilcoxon rank sum test,  as appropriate. A p  < 0.05 was considered 
significant. 
RESULTS 
Stimulation of the Respiratory  Burst by fMLP-The che- 
motactic peptide, fMLP, caused a transient stimulation of 
H202 release from normal PMNL (Fig. 1). Cytochalasin B 
has been reported to slightly prolong the response to fMLP 
(43); however, even with cytochalasin preincubation, the re- 
sponse began to decrease within 1 min and had completely 
ceased within 2.5 min after  stimulation (Fig. 1). Most inves- 
FIG. 1. Tracing of HsOz release induced by 10 nM fMLP and 
modulation of the response after preincubation with the di- 
acylglycerol, AAG(18:l-2:O). Prior to stimulation by fMLP, 
PMNL were preincubated for 10 min with the indicated concentra- 
tions of  AAG(181-2:O) (0,2,3, or 10 pM) and for 2 min with 5 pg/ml 
cytochalasin B. The vertical bar represents the equivalent of 10 nmol 
of H202 released from 10’ PMNL. Similar results were observed in 
14 separate PMNL preparations. 
2o T 
=I$. 0 0 10 20 30 40 50 
AAG( 18: 1 -2:O). pLM 
FIG. 2. Priming of fMLP-stimulated HzOz release by prein- 
cubation with  varying concentrations of AAG(18:1-2:0). The 
initial velocity (V& of HzO2 release is the slope usually measured in 
such responses. Since responses to  fMLP alone were always flat (0) 
by 3 min, the velocity after  3 min ( V3 was used as an indicator of 
prolongation of the response. Experimental conditions were as de- 
scribed for Fig. l. Data  are means * S.E. from 14 PMNL preparations 
and are nmol  Hz02 released/rnin/lO’ PMNL. 
tigators studying fMLP stimulation of PMNL employ cyto- 
chalasin B to obtain an optimal and reproducible response. 
In this study, unless specified otherwise, cytochalasin B, 5 
pg/ml, was added 2 min before fMLP. Under these conditions, 
10 nM fMLP (the  concentration used in the priming experi- 
ments) directly stimulated 5.07 f 0.35 nmol/min HzOz release 
(initial rate; n = 18), and 1 pM fMLP (a maximally effective 
concentration)  stimulated 24.4 f 1.54 nmol/min ( n  = 5). 
Priming of the  Respiratory  Burst by  Diacylglycerok, 
AAG(18:1-2:20) and AAG(8:0-8:O)-Preincubation of PMNL 
with AAG(181-2:O) caused a  shortening of the lag time  and 
up to a 3-fold enhancement of the initial  rate of the response 
to subsequent fMLP stimulation (Figs. 1 and 2). AAG(181- 
2:O) also caused a  concentration-related prolongation (or lack 
of termination) of the response. With priming by 50 pM 
AAG(18:l-2:0), HzOz release continued nearly unabated for 
the 6-min duration of the experiments (data  not shown). To 
provide a means of quantitating  duration,  the  rate of Hz02 
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release was determined 3 min after fMLP stimulation. In 
unprimed PMNL, the Vsmin was always zero. However, in 
PMNL primed with AAG( 18:l-2:0), the concentration-related 
prolongation, reflected in the increasing Vsmin, is shown in 
Fig. 2. Under the conditions employed (preincubation with 
diglyceride prior to addition of cytochalasin B), there was 
little direct stimulation by AAG(18:l-2:O) up to 50 pM (at 
which the  rate was 2.91 nmol/min). 
AAG(8:O-80) has been reported to stimulate the respiratory 
burst of PMNL  (32), presumably by activation of PKC (44). 
In the present  study, AAG(80-8:O)  was much more potent  as 
a direct stimulant than AAG(181-2:0), with significant stim- 
ulation observed at  210 p ~ .  However, at low concentrations 
(2-4 p ~ ) ,  AAG(8:O-8:O) caused minimal direct stimulation 
(approximately 1 nmol HzOz/min), but caused priming of 
both  initial velocity and  duration of the response to fMLP. 
Priming with 3 p~ AAG(8:O-8:O) increased the fMLP Vinit 
from 3.9 f 0.56 (controls) to 12.9 f 1.4  (primed) nmol HzOz/ 
min (n = 3). The VZmin was increased from 0 to 4.49 & 0.71 
nmol/min. 
Priming by 1 -0-Alkyl-2-acyl-glycerols-The EAG analog, 1- 
O-A9-octadecenyl-2-acetyl-sn-glycerol (EAG(18:l-2:O)) also 
shortened the lag time (Fig. 3) and primed the initial  rate of 
the oxidative burst induced by fMLP (Figs. 3  and 4). However, 
EAG(18:l-2:O) had  little or no effect on the duration of the 
response (Fig. 3). With EAG(181-2:O) priming, the velocity 
after  3 min was always 0 (13 separate  PMNL  preparations). 
In contrast to the potent direct stimulatory effects of 
AAG(80-8:0), EAG(8:O-80) had no effect as  a direct stimu- 
lant of H202 release (data  not shown). However, it was able 
to prime the initial  rate of the response to fMLP, although 
10 rrn 
/ 
cu 5 rm 
10 n M  fMLP 
I 
1 min ' 
FIG. 3. Modulation of the fMLP-induced H 2 0 2  release 
caused by preincubation with the 1-0-alkyl-2-acyl diglycer- 
ide, EAG(18:l-2:O). PMNL were preincubated with 0 (buffer 
alone), 5 or 10 PM EAG(181-2:0), as indicated adjacent to the 
tracings, and were stimulated with 10 nM fMLP. Similar responses 
were consistently observed in 13 PMNL preparations. 
T 
2 4  
I 
0 
0 20 40 60 80 100 
EAG(18:1-2:0), pM 
FIG. 4. Priming of fMLP-stimulated H z 0 2  release by prein- 
cubation with  varying concentrations of EAG(18:1-2:0). Con- 
ditions were as described for Fig. 1. Data are means k S.E. from 13 
PMNL preparations. 
less potently than EAG(181-2:O). After preincubation with 
buffer alone or with 20, 30, or 50 pM EAG(80-80), 10 nM 
fMLP elicited H202 release (Vi& of  4.6 f 0.14,  6.8 & 0.4,  7.1 
& 0.8, and 11.25 f 1.1 nmol/min, respectively (n = 5). The 
kinetics of H202 release were similar to  that observed with 
priming by EAG(18:l-2:0), except that EAG(80-8:O) did 
cause slight prolongation of  Hz02 release, with V3min of  0.66 
f 0.44, 0.97 f 0.48, and 1.0 f 0.48 nmol/min after priming 
with 20, 30, or 50 p~ diglyceride,  respectively. 
Two other alkylacylglycerols EAG( 16:O-2:O) and EAG( 18: 1- 
3:O) had priming activity comparable to  that of EAG(18:l- 
2:O). EAG(16:O-6:O) caused only slight priming, perhaps due 
to  the longer  acyl chains hindering permeability into  the cell. 
The 1,3-isomer of EAG(8:O-8:O) and  the dialkyl diglyceride, 
1-0-hexadecyl-2-0-ethyl-sn-glycerol were inactive (data  not 
shown). 
Effect of Platelet Activating Factor on Stimulation by 
fMLP-Dig1yceride:CDP-choline phosphotransferase, which 
is present  in  PMNL  (45), could convert EAG(18:l-2:O) to 1- 
0-octadecenyl-2-acetyl-sn-glycerophosphocholine (PAF( 18 
1-2:O)). Since PAF  has been reported to prime the respiratory 
burst of PMNL (9, l l ) ,  it was considered possible that priming 
by  EAG(18:l-2:O)  was mediated by conversion of the diglyc- 
eride to PAF(18:l-2:O).  However, with the experimental pro- 
tocol used in these studies, including cytochalasin B, PAF 
had little priming effect on the response of fMLP. After 
preincubation with 0, 1, 10, 100, and 1000 nM PAF, stimula- 
tion by 10 nM fMLP caused a H202 Vinit of 7.4 f 0.3, 6.2 f 
0.6, 6.1 f 0.9, 8.3 f 1.2, and 9.7 f 0.8 nmol/min (n = 8), 
respectively, with no prolongation of the response. In separate 
preliminary experiments, we have found that PAF will prime 
to  the weaker fMLP-induced response when cytochalasin B 
is not included in the preincubation medium (data  not shown), 
as reported previously (9, l l ) .  In  contrast,  as noted above, the 
diglycerides  were able to prime the optimal fMLP response, 
generated with inclusion of cytochalasin B. The significance 
of this remains under investigation. However, these data 
would suggest that priming by PAF  and by the diglycerides 
involve different mechanisms. 
Effect of Removal of Extracellular Diglyceride Prior to 
Primed Stimulation-The experimental protocol used for the 
above priming studies employed 10-min preincubation with 
diglyceride  before stimulation with fMLP.  Preliminary exper- 
iments had shown that 4-10-min preincubation was optimal, 
but significant priming occurred even when  diglyceride and 
fMLP were added simultaneously (data not shown). Since 
residual diglyceride might remain after the 10-min preincu- 
bation, these data could not distinguish whether priming 
involved 1) cellular alterations which persist with time, or 2) 
synergy between residual diglyceride and  other  fMLP-induced 
events  (in  particular,  transiently increased cytosolic free Ca2+) 
which  would require interaction of diglyceride and  other me- 
diators (e.g. Ca2+) at the time of fMLP stimulation. Two 
experiments were used to test these possibilities. The first 
involved washing the cells after priming, to remove extracel- 
lular diglyceride. The second involved reversal of the priming/ 
stimulation sequence. 
If diglyceride-mediated priming involved synergy with Ca2+ 
to induce PKC  translocation to cellular membranes (46-48), 
then washing of PMNL  to reduce diglyceride concentration 
should be  followed  by dissociation of membrane-bound PKC 
(49) and loss of the priming effect. If PMNL were preincu- 
bated with diglyceride for 2.5 min and  then washed free of 
extracellular diglyceride by centrifugation, both AAG(181- 
2:O) and EAG(18:1-2:0) still caused significant priming of the 
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responses induced by fMLP. Whereas 10 nM fMLP elicited a 
vinit of 4.81 f 1.0 nmol H202/min, priming by  20 p~ 
AAG(18:1-2:0) or 20 ~ L M  EAG(18:l-2:0), and washing by 
centrifugation, increased the Vinit to 15.1 2 0.9 and 18.5 f 0.9 
nmol/min, respectively (n  = 3). After AAG(18:l-2:O) priming 
and washing, the V3min remained elevated, although it was 
somewhat decreased compared with unwashed PMNL. The 
ratio of V3min/Vinit of unwashed, AAG-primed PMNL was 
0.40 f 0.06 and  after washing was  0.27 f 0.06, n = 3. In two 
experiments, similar priming persisted even for 60 min after 
washing PMNL free of diglyceride, but  after such prolonged 
preincubation the Vsmin was  reduced to nearly zero (data  not 
shown). These experiments could not absolutely exclude con- 
tribution by residual intracellular diglyceride but do indicate 
that continuous presence of the relatively high concentrations 
of diglyceride, added initially, are  not needed for priming. 
Priming of fMLP and Stimulation by AAG or EAG-If 
fMLP were used to prime PMNL, the fMLP-induced increase 
in cytosolic Ca2+ would decay to control levels well before 
exposure of the cells to diglyceride, 10 min later. This agonist 
sequence (fMLP priming, followed after 10 min with diglyc- 
eride stimulation) could therefore be used to  test whether a 
transient increase in cytosolic Ca2+ is necessary for primed 
stimulation. Whereas 10 p~ AAG(181-2:O) alone caused min- 
imal direct stimulation (1.31 f 0.93 nmol/min), priming by 
10 nM fMLP markedly enhanced H202 release to 15.1 f 2.05 
nmol/min/107 PMNL, n = 6. In contrast, EAG(181-2:0), 
which had no ability to directly stimulate PMNL at any 
concentration  tested  (up to 300 pM),  also caused little HzO2 
release from PMNL even after priming with fMLP (0.46 k 
0.28 nmol/min after primed stimulation with 10 pM 
EAG(181-2:0), similar results  after 20, 30, or 50 p~ diglyc- 
eride, n = 3). 
Interaction of 1,2-Diacyl and 1 -Alkyl-2  Glycerides in  Priming 
and in Direct Stimulation of PMNL-Since EAGs could not 
prime for a prolongation of the fMLP-induced response, and 
higher concentrations (50-100 p ~ )  of EAG(18:1-2:0) lost 
ability to prime initiation, it was considered possible that 
EAG,  especially at higher concentrations, might inhibit  prim- 
ing or stimulation of PMNL. PMNL were preincubated with 
a  constant  amount (e.g., 10 p ~ )  of AAG(181-2:O) and varying 
concentrations of EAG(18:l-2:O) (Fig. 5). At 5 pM EAG(181- 
2:0), there was a modest but significant ( p  < 0.01) increase in 
both Vi,it and V3 min responses to  fMLP (although the effects 
of  AAG plus EAG  were  always less than additive). At higher 
concentrations of EAG(18:l-2:0), there was concentration- 
related inhibition of the AAG-primed responses. The inhibi- 
tory effect appeared to have the greatest influence on the 
prolongation of the response. At 70 pM EAG(181-2:0), the 
V3min was reduced to zero, whereas the initial velocity was 
reduced by 52%. 
Direct stimulation of unprimed PMNL by higher concen- 
trations of AAG(18:l-2:O)  was inhibited by EAG(18:l-2:0), in 
a  concentration-related manner (Fig. 6). A Dixon plot  (inset 
to Fig. 6) indicated that EAG competitively inhibited AAG 
with an effective Ki  of about 20 pM EAG(18:1-2:0). 
Inhibition of Activation of the PKC of Human  PMNL by 
EAG(18;1-2:O)-Direct stimulation of PMNL by AAG(18:l- 
2:0), 250 p ~ ,  p,robably  involves activation of PKC, since the 
stimulation has been shown to be markedly reduced by an 
isoquinoline sulfonamide inhibitor of PKC  (14,50)  and AAG 
stimulation correlated with translocation of PKC to the 
plasma membrane of PMNL (14). Since EAG inhibited AAG- 
mediated priming and  stimulation, the stimulatory and  inhib- 
0 
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FIG. 5. Modulation of HaOa release  after preincubation with 
both AAG(18:l-2:O) and EAG(18:l-2:O). PMNL were prein- 
cubated with a constant amount of AAG(181-2:O) combined with 
varying concentrations of EAG(181-2:O) and were then stimulated 
with 10 nM fMLP. Data are from eight PMNL preparations employ- 
ing 10 p~ AAG(181-2:0), two preparations using 20 pM AAG(181- 
2:0), and three preparations with 30 p~ AAG(181-2:O). Since the 
effect of EAG(181-2:O) appeared independent of AAG(181-2:O) con- 
centrations within this range (see Fig. 2), the  data were combined in 
the figure. The effects on initial velocity (Vinic) and velocity after 3 
min (Vamin) (as an indicator of prolongation) are shown. In these 
experiments, fMLP alone (without priming) induced a Vinic of 6.4 f 
0.9 nmol/min; V, min was always 0. 
0 4  
0 25 50 75 100 125 150 
EAG( 18: 1 - 2 : 0 ) ,  p M  
FIG. 6. Inhibition by EAG(18:l-2:O) of the direct stimula- 
tion by AAG(18:l-2:O). PMNL were preincubated with 5 pg/ml 
cytochalasin B for 2 min and were then stimulated with 70 (0) or 100 
p~ (0) AAG(181-2:O) in  the presence of the indicated concentrations 
of EAG(181-2:O). Data are means k S.E., n = 3. In the inset, the 
same data are plotted according to  the method of Dixon (53) to allow 
determination of the effective Ki of EAG(181-2:O). 
itory effects of EAG on activity of PKC were examined in 
vitro. 
EAG(18:l-2:0), 0.26-78 p~ (Fig. 7),  and EAG(160-2:O) 25 
p~ (data  not shown) had no demonstrable ability to activate 
PKC(s)  in cytosolic fractions from PMNL.  In  contrast, high 
concentrations of EAG(8:O-8:O) did cause histone phospho- 
rylation (Fig. 7). However, a 100-fold greater concentration 
of EAG(80-8:O)  was required to cause phosphorylation equiv- 
alent to  that induced by the diacyl species AAG(80-80)  and 
AAG(18:l-2:O) (Fig. 7). The increased activity induced by 
AAG(16:l-2:O) and  EAG(80-80) was completely lost if either 
Ca2+ or phosphatidylserine were not included in the incuba- 
tion. Activation by  AAG(80-8:O) required presence of phos- 
phatidylserine, but  partial activation (30-40% of the complete 
Ca2+/phosphatidylserine/AAG(80-80) system) occurred in 
absence of added Ca2+ (data  not shown). 
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FIG. 7. Activation of protein kinase C in cytosolic fractions 
of human  PMNL by diglycerides. PKC activity was assayed as 
described under “Experimental Procedures.” Data shown are for 
histone phosphorylation in the presence of 0.2 mM free Ca2+ and 10 
pg/ml phosphatidylserine without addition of diglyceride (0) or with 
addition of the indicated concentrations of  AAG(181-2:O) (O), 
AAG(80-80) (O), EAG(181-2:O) (A) or EAG(80-80) (A). Phospho- 
rylation in absence of both Ca2+ and phosphatidylserine (60 pmol/ 
min) was unchanged by diglycerides and has been subtracted from all 
points shown. Data are expressed as pmol of 32P incorporated/min/ 
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FIG. 8. Effect of EAG(18:l-2:O) on PKC activation by 
AAG(18:l-2:O). Assays were conducted in the presence of the 
indicated concentrations of AAG alone (A) or with further addition 
of 50 p M  (0) or 130 p~ (m) EAG(18:1-2:0). The curves were drawn 
by nonlinear regression analysis, employing a rectangular hyperbolic 
(Michaelis-Menten) model. Histone phosphorylation in the absence 
of diglyceride activator was subtracted from each point. Data are 
means of closely agreeing triplicate  determinations from a  represent- 
ative experiment, with similar results with three separate PMNL 
cytosol preparations.  In all instances, the regression model fit with a 
high correlation coefficient ( r2  > 0.99). 
Nonlinear regression analysis indicated that AAG( 181-2:0) 
activated  PKC with rectangular hyperbolic kinetics, with an 
effective K, of 0.45 & 0.04 pM AAG and  a V,, of  412 pmol/ 
min/107 PMN equivalents ( n  = 3) (Fig. 8). Addition of 50 or 
130 p~ EAG(18:1-2:0) reduced the activation of PKC by 
AAG(181-2:O). The predominant effect of 50 p~ EAG(181- 
2:O) was to increase the  apparent K,,, for AAG more than 10- 
fold, to 6.3 f 1.8 PM AAG(18:l-2:0), with a slight (8%) 
decrease in the V,, to 380 f 8 pmol/min/107 cell equivalents 
( n  = 3) (Fig. 8). Higher (130 PM) EAG(18:l-2:O) had little 
further effect on the K,  but did cause greater decrease in  the 
Vmax (247 & 31 pmol/min/107 cell equivalents) ( n  = 3). 
DISCUSSION 
Both AAGs and EAGs are released following stimulation 
of human PMNL (29-31) or HL-60 myeloid leukemia cells 
(51). AAGs can directly stimulate the respiratory burst of 
PMNL (20, 50) in correlation with translocation  and activa- 
tion of PKC (14). However, the bioactivities of EAGs in 
PMNL have not been defined. In  this study, EAGs had no 
ability to directly stimulate the respiratory burst of PMNL. 
However, at low concentrations, EAGs  were capable of prim- 
ing the initiation of H202 release when PMNL were stimu- 
lated with fMLP. At higher concentrations, EAGs lost this 
priming effect and actually inhibited priming induced by 
AAGs. Thus, EAGs  may  have bimodal modulatory effects on 
PMNL responses. At low concentrations, EAGs  may facilitate 
initiation of functions such as  the respiratory burst. At higher 
concentrations, EAGs  may  be  involved in  termination of the 
response. The distinct effects of  AAGs and EAGs also revealed 
an important aspect of priming of the respiratory burst of 
PMNL.  Priming occurs in at least two phases, initiation  and 
duration. AAG and EAG(181-2:O) primed initiation of the 
burst with comparable efficiencies, yet only the diacyl species 
had a major effect on the duration of the response. Thus, 
activation of the NADPH oxidase and ongoing maintenance 
of oxidase activity appear to involve different transductional 
events. 
The mechanisms of priming are largely unknown. AAGs 
are endogenous activators of PKC. However, several lines of 
data suggest that diglyceride priming, at least of initiation, 
may involve mechanisms other than PKC activation. We 
recently reported that priming by the diacylglycerol, 
AAG(181-2:O) was not influenced by the isoquinoline sulfon- 
amide inhibitor of PKC, C-I (14),  and that priming occurred 
at AAG concentrations which did not induce detectable trans- 
location of PKC to PMNL membranes (14). Those data 
suggested that priming by  AAG did not require PKC activa- 
tion,  but  other  interpretations of the  data remained possible. 
It could  be that priming requires activation of only a small 
portion of total cellular PKC, which might be incompletely 
blocked  by the PKC inhibitor. The priming effect might not 
require PKC  translocation, or (perhaps more likely) the bio- 
chemical assay of total cellular PKC might not be sufficiently 
sensitive to detect  shifts in a small subcompartment of the 
kinase. The current  studies significantly extend the previous 
data. 
One proposed mechanism regarding enhancement of PKC 
activation by  low diglyceride concentrations would involve a 
diglyceride-mediated increase in affinity of PKC for cytosolic 
Ca2+, perhaps by translocation of PKC to  the plasma mem- 
brane (46, 48). Transiently increased cytosolic CaZ+, induced 
by fMLP, would then cause enhanced  stimulation of the cell 
through PKC-mediated events. Phorbol esters cause such 
translocation and increased Ca2+ affinity of PKC (46). A 
similar enhanced responsiveness mediated by diglycerides 
would  be anticipated. After decreasing the phorbol ester con- 
centration, the effects were rapidly reversed (46, 49). Con- 
versely, Dougherty and Niedel (48) studied HL-60 myeloid 
leukemia cells and reported that agonists which increase 
cytosolic Ca2+, including fMLP, cause increased affinity of 
PKC for phorbol esters  and result in a lower concentration of 
phorbol ester required for cellular stimulation. The duration 
of upregulation of phorbol ester binding of PKC correlated 
with the transient increase in Ca2+ induced by fMLP (3-4 
min of duration)  (48). This mechanism of diglyceride/Ca2+/ 
PKC  interaction is perhaps  better considered as synergy, since 
both diglyceride-mediated and Ca2+-mediated events occur 
concomitantly. In  contrast, priming implies sequential events, 
with the primed condition persisting beyond the immediate 
application of the priming agent.  Thus, diglyceride priming 
was effective for 10-60 min after removal of extracellular 
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diglyceride. And fMLP-priming was effective (for PMNL 
stimulated with AAG) after the fMLP-induced changes in 
cytosolic Ca2+  had  returned  to  resting levels. 
EAG(18:l-2:0), which had  no  demonstrable  ability  to  acti- 
vate  PKC, caused priming of initiation with  a potency  iden- 
tical to that of AAG(18:l-2:O). This further supports the 
hypothesis  that  priming of initiation occurs  by mechanisms 
other  than  activation of PKC. 
Whether priming of a prolonged response is also PKC 
independent  is  not proven. Priming of prolongation occurred 
with diacylglycerols, which  could activate  PKC,  but  did  not 
occur with alkylacylglycerols, EAG(18:l-2:O) and EAG(16:O- 
2:0), which do not  activate  PKC.  Interestingly, EAG(8:O-8:0), 
which had a weak ability  to  activate  PKC, also  caused slight 
prolongation of the response to  fMLP.  Higher  concentrations, 
50-100 /AM, of EAG(18:l-2:O) inhibited  priming (especially of 
prolongation) induced by AAG(18:l-2:0), and  inhibited  acti- 
vation of PKC in vitro. Thus,  priming of prolongation  and 
the  ability  to  activate  PKC occur, at  least  to some degree, in 
parallel. 
The abilities of 50-100 /AM EAG(18:l-2:O) to terminate 
priming, to  inhibit  direct  s imulation by 70-100 p~ 
AAG(18:l-2:0), and  to  inhibit  activation of PKC by 
AAG(18:l-2:0), suggest that elevated concentrations of en- 
dogenous EAGs  might  act  to  terminate  certain cellular func- 
tions, especially those involving PKC activation. EAGs are 
released following fMLP stimulation of PMNL, but EAG 
release is delayed for about 2 min following stimulation: 
Thus,  detectable  increases  in  EAGs may  occur at about  the 
time of termination of the  normal response to  fMLP.  It is 
possible that  the  termination  is nfluenced by EAG-mediated 
inhibition of PKC. 
Observations of effects of EAGs  on  activity of PKC have 
not been entirely uniform. Variable results could relate to 
different  EAGs  examined  or  to differences in  PKC isozymes 
in the different tissues studied. It has been suggested that 
different isozymes of PKC are differentially modulated by 
fatty acids (52). Whether specific PKC isozymes might be 
selectively influenced by EAGs  has  not  been reported. Cabot 
and  Jaken (33) reported  that EAG(16:O-2:O) did  not  activate 
PKC  from mouse brain,  but  did  not  test  for  inhibition of  AAG 
activity. Daniel et al. (35) recently  found  that EAG(181-2:O) 
and EAG(16:O-2:O) had  no  ability  to  activate  PKC  and  inhib- 
ited AAG(18:l-2:O) activation of PKC(s) from HL-60 cells. 
In  contrast,  Heymans et al. (34) studied  phosphorylation of a 
43-kDa protein  in  platelets  and  reported  that EAG(10:O-10:O) 
had  about 10% of the  stimulatory  activity of AAG( 1O:O-1O:O); 
EAG( 16:O-2:0) had only slight  activity,  and  EAG( 18:O-2:O) 
was inactive. This suggests that  the  ability of EAGs  to  activate 
or  inhibit  PKC  might  relate  to  the  fatty acid  composition of 
the diglyceride. This  hypothesis  is  supported by the observa- 
tion  that EAG(8:O-8:0), but  not EAG(181-2:0),  was able at  
high concentrations to  activate  PKC  in cytosolic fractions of 
human  PMNL. Endogenous  species of alkyl-linked PCs  con- 
tain  primarily  long  chain residues (18:0, 16:0, 189) in  the sn- 
1 position  (28). Since  such long chain  EAGs have been  found 
not  to  activate  PKC  and, where tested,  to  inhibit  PKC activ- 
ity,  the  hypothesis  that  inhibition of PKC might be a natural 
function of such  EAGs  is reasonable, albeit speculative at  this 
time. 
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